SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-024178
Filing Date
2021-02-16
Accepted
2021-02-16 16:33:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216840d21_sc13ga.htm SC 13G/A 42212
  Complete submission text file 0001104659-21-024178.txt   43705
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Subject) CIK: 0001627281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89356 | Film No.: 21639389
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

IRS No.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A